Bernard B. Lanter, Ph.D.

Bernard B. Lanter, Ph.D. has a diverse work experience in the field of life sciences. Bernard B. started their career as a Graduate Teaching Assistant at Binghamton University, where they taught various science classes and conducted laboratory activities. During this time, they also conducted research on the role of bacterial infection in atherosclerosis within the human carotid artery.

After completing their Ph.D., Lanter moved on to work as a Postdoctoral Research Fellow at Massachusetts General Hospital and Harvard Medical School. In these roles, they focused on dissecting the signaling pathways between infected epithelial cells and the resulting immune response. Bernard B. utilized the CRISPR/Cas9 genome editing technique to study genes involved in eicosanoid synthesis and their impact on immune cell migration in response to bacterial infection.

Lanter then joined Kintai Therapeutics as a Research Scientist, where they contributed to various research projects. Bernard B. later advanced to the role of Senior Research Scientist, further demonstrating their expertise in the field.

Lanter's career progression continued at Immunitas Therapeutics, where they worked as a Senior Scientist. In this position, they continued to contribute to scientific research and development.

Currently, Lanter is employed at Xilio Therapeutics, Inc. as a Senior Scientist. Bernard B.'sresponsibilities include building out the company's Cell Line Engineering capabilities, generating cell lines, and establishing in vitro assays and in vivo model development.

Overall, Bernard B. Lanter, Ph.D. has accumulated extensive experience in scientific research, with a focus on immunology, microbiology, and cell biology. Bernard B. has a track record of contributing to cutting-edge research and is skilled in utilizing advanced techniques and technologies in their work.

Bernard B. Lanter, Ph.D. earned a Bachelor of Arts (B.A.) degree in Chemistry from Binghamton University in the years 2007-2011. Bernard B. then went on to pursue further education at the same university and obtained a Doctor of Philosophy (PhD) degree in Biochemistry, Cell and Molecular Biological Sciences from 2011-2015.